- Home
- LKQ vs KYMR Comparison
LKQ vs KYMR Comparison
Compare LKQ & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LKQ | KYMR |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 6.8B |
| IPO Year | 2003 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LKQ | KYMR |
|---|---|---|
| Price | $29.35 | $79.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 26 |
| Target Price | $42.33 | ★ $108.04 |
| AVG Volume (30 Days) | ★ 2.0M | 699.7K |
| Earning Date | 05-22-2026 | 05-18-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.35 | N/A |
| Revenue | ★ $13,651,000,000.00 | $39,211,000.00 |
| Revenue This Year | $2.01 | $16.05 |
| Revenue Next Year | $1.64 | $4.79 |
| P/E Ratio | $12.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.13 | $19.45 |
| 52 Week High | $43.47 | $103.00 |
Technical Indicators
Market Signals| Indicator | LKQ | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 27.51 | 41.62 |
| Support Level | N/A | $77.78 |
| Resistance Level | $32.08 | $95.90 |
| Average True Range (ATR) | 0.90 | 4.58 |
| MACD | -0.38 | -1.57 |
| Stochastic Oscillator | 2.68 | 9.76 |
Price Performance
Historical ComparisonAbout LKQ LKQ Corporation
LKQ Corp is a world-wide distributor of vehicle products, including replacement parts, components and systems used in the repair and maintenance of vehicles, and specialty aftermarket products and accessories to improve the performance, functionality and appearance of vehicles. The company is organized into three operating segments: North America; Europe; and Specialty segment. It derives maximum revenue from Europe Segment. Europe segment is a provider of alternative vehicle replacement and maintenance products in Germany, the United Kingdom, the Benelux region (Belgium, Netherlands, and Luxembourg), Italy, Czech Republic, Austria, Slovakia, France and various other European countries.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.